Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-10-30 Ege David S. Sale 10b5-1 −4,066 $1.35 $5K 66,991
2023-10-30 von Moltke Lisa Sale 10b5-1 −4,232 $1.35 $6K 9,513
2023-10-30 Henn Matthew R. Sale 10b5-1 −3,886 $1.35 $5K 56,356
2023-10-27 Cloghessy Paula Exercise or conversion 10b5-1 +9,418 48,588
2023-10-27 Cloghessy Paula Exercise or conversion · Restricted Stock Units 10b5-1 −9,418 9,417
2023-10-27 Shaff Eric D. CEO and President Exercise or conversion 10b5-1 +27,838 124,172
2023-10-27 Shaff Eric D. CEO and President Exercise or conversion · Restricted Stock Units 10b5-1 −27,838 27,837
2023-10-27 Young Teresa L. Exercise or conversion 10b5-1 +11,361 11,361
2023-10-27 Young Teresa L. Exercise or conversion · Restricted Stock Units 10b5-1 −11,361 11,360
2023-10-27 Arkowitz David Chief Financial Officer Exercise or conversion 10b5-1 +13,209 179,822
2023-10-27 Arkowitz David Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −13,209 13,209
2023-10-27 DesRosier Thomas Chief Legal Officer and EVP Exercise or conversion 10b5-1 +13,501 118,047
2023-10-27 DesRosier Thomas Chief Legal Officer and EVP Exercise or conversion · Restricted Stock Units 10b5-1 −13,501 13,500
2023-10-27 Ege David S. Exercise or conversion 10b5-1 +11,361 71,057
2023-10-27 Ege David S. Exercise or conversion · Restricted Stock Units 10b5-1 −11,361 11,360
2023-10-27 von Moltke Lisa Exercise or conversion 10b5-1 +13,745 13,745
2023-10-27 von Moltke Lisa Exercise or conversion · Restricted Stock Units 10b5-1 −13,745 13,744
2023-10-27 Henn Matthew R. Exercise or conversion 10b5-1 +12,623 60,242
2023-10-27 Henn Matthew R. Exercise or conversion · Restricted Stock Units 10b5-1 −12,623 12,622
2023-06-22 Biondi Paul Director Grant or award · Stock Option (right to buy) +35,000 35,000

Page 17 of 23 · 458 trades